期刊文献+

葡萄糖苷酶Ⅰ特异性siRNA-EGFP真核表达载体的构建及表达 被引量:3

Construction and Expression of GlucosidaseⅠSpecific siRNA Eukaryotic Expression Vector
下载PDF
导出
摘要 目的:构建葡萄糖苷酶Ⅰ(glucosidaseⅠ, GluⅠ)特异性siRNA真核表达载体。方法:根据 siRNA靶序列选取原则,设计并合成针对鼠葡萄糖苷酶ⅠcDNA的寡聚DNA,退火并连接至载体 pSilencer1.0 U6,再将 U6 启动子及下游插入片断一起切下,克隆至真核表达载体 pEGFP C1,通过限制性酶切和测序对重组表达载体进行鉴定,最后将该质粒转染至HeLa细胞,共聚焦荧光显微镜观察其表达。结果:①限制性酶切和测序结果表明成功构建了带有EGFP基因的鼠GluⅠ特异性的siRNA真核表达载体 pC 1U6glu; ②共聚焦荧光显微镜观察结果表明p C1U6glu成功转染至HeLa细胞。结论:pC 1U6glu的成功构建及表达为进一步利用 siRNA研究葡萄糖苷酶Ⅰ的功能和治疗肿瘤奠定基础。 Objective: To construct eukaryotic expression vector of siRNA specific for rat glucosidaseⅠ. Methods: According to the selection guideline of siRNA target sequence, oligonucleotides were designed and synthesized, annealed and inserted into pSilencer 1.0-U6 , subsequently. The U6 promoter linked with the sequence coding glucosidaseⅠ-siRNA was subcloned into pEGFP-C1. The recombinant plasmid was confirmed by restriction enzyme digestion and DNA sequencing. The recombinant eukaryotic expression vector was transfected into HeLa cells and detected by the confocal fluorescence microscope. Results: The construction of glucosidaseⅠ-specific siRNA eukaryotic expression vector pC-1U6glu and its transfection into HeLa cells were confirmed successfully by the restriction digestion and confocal microscope analysis. Conclusion: The expression of pC-1U6glu in HeLa cells lays the foundation by using siRNA to study the function of glucosidaseⅠand its further application for tumor therapy.
出处 《武汉大学学报(医学版)》 CAS 2005年第2期190-193,i002,共5页 Medical Journal of Wuhan University
基金 国家自然科学基金资助项目 (编号:30370310) 湖北省卫生厅资助项目(编号:JX1BO74)
关键词 葡萄糖苷酶Ⅰ SIRNA 真核表达载体 Glucosidase Ⅰ siRNA Eukaryotic Expression Vector
  • 相关文献

参考文献8

  • 1Elbashir SM, Lendeckel W, Tuschl T, et al. RNAinterference is mediated by 21- and 22-nucleotide RNAs. Genes Dev, 2001, 15:188.
  • 2Sui GC, Christina S, Bachir EI, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA, 2002,99: 5 515.
  • 3Thijn R, Brummelkamp R, Smith L. et al. A system for stable expression of short interfering RNAs in mammalian cells. Science, 2002, 296:550.
  • 4Senitiroh H. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc Natl Acad Sci, 2002, 99:10 231.
  • 5Tuschl T, Zamore PD, Lehmann R, et al. Targeted mRNA degradation by doublestranded RNA in vitro. Genes Dev, 1999, 13:3 191.
  • 6Lowe JB, Warner RL, Smith PL, et al. Glycosylation, immunity and autoimmunity. Cell, 2001, 104: 809.
  • 7Guo HB, Liu F, Chen HL, et al. Increased Susceptibility to Apoptosis of Human Hepatocarcinoma Cells Transfected with AntisenseN-Acetylglucosaminyltransferase V cDNA. Biochem Biophys Res Commu, 1999, 264:509.
  • 8Nancy Y, Marcus R, David H, et al. Glucosidase and mannosidase inhibitors mediate increased secretion of mutant 1 antitrypsin Z. J Biol Chem, 2000, 275: 1 987.

同被引文献3

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部